Very early changes in olfactory functioning due to Alzheimer's disease and the role of Apolipoprotein E in olfaction

Annals of the New York Academy of Sciences

Volumn 855, Issue , 1998, Pages 723-731

  Bacon, Anna W ^a   Bondi, Mark W ^b,c,d   Salmon, David P ^c   Murphy, Claire ^a,c,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e SAN DIEGO STATE UNIVERSITY   (United States)

^f Life Span Human Senses   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OLFACTORY DISCRIMINATION; SMELLING;

EID: 0032460790     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10651.x     Document Type: Conference Paper

References (47)

1. 1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th edit. : 123-163. American Psychiatric Association. Washington, DC.
2. 2. Farrer, L. A., L. A. Cupples, C. M. Van Duijn, A. Kurz, R. Zimmer, U. Muller, R. C. Green, V. Clarke, J. Shoffner, D. C. Wallace, H. Chui, S. D. Flanagan, R. Duara, P. St. George-Hyslop, S. A. Auerbach, L. Volicer, J. Wells, C. Van Broeckhoven, J. H. Growdon & J. L. Haines. 1995. Apolipoprotein E genotype in patients with Alzheimer's disease: Implications for the risk of dementia among relatives, Ann. Neurol. 38(5): 797-808.
3. 3. Katzman, R. & C. Kawas. 1994. The epidemiology of dementia and Alzheimer disease. In Alzheimer Disease. R. D. Terry, R. Katzman & K. L. Bick, Eds. : 105-122. Raven Press. New York.
4. 4. Katzman, R. 1993. Education and the prevalence of dementia and Alzheimer's disease. Neurology 43: 13-20.
5. 5. Stern, Y., B. Gurland, T. K. Tatemichi, M. X. Tang et al. 1994. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271: 1004-1010.
6. 6. Van Duijn, C. M., T. Stijnen & A. Hofman. 1991. Risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20(2) (Suppl. 2): S4-S12.
7. 7. Mahley, R. W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622-629.
8. 8. Ignatius, M. J., P. J. Gebicke-Harter, J. H. Pate Skene, J. W. Schilling, K. H. Weisgraber, R. W. Mahley & E. M. Shooter. 1986. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA 83: 1125-1129.
9. 9. Elshourbagy, N. A., W. S. Liao, R. W. Mahley & J. M. Taylor. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present other tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA 82: 203-207.
10. 10. Das, H. K., J. McPherson, G. A. P. Brun et al. 1985. Isolation characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260: 6240-6247.
11. 11. Olaisen, B., P. Teisberg & T. Gedde-Dahl. 1982. The locus for apolipoprotein E (ApoE) is linked to the complement component C3 (C3) locus in chromosome 19 in man. Hum. Genet. 62: 233-236.
12. 12. Sing, C. F. & J. Davingnon. 1985. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37: 268-285.
13. 13. Namba, Y., M. Tomonaga, H. Kawasaki, E. Otomo & K. Ikeda. 1991. Apolipoprotein E immunoreactivity in cerebral amalyoid deposits and neurofibrillary tangles in Alzheimer's disease. Brain Res. 541: 163-166.
14. 14. Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. S. Salvesen & A. D. Roses. 1993. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
15. 15. Wisniewski, T. & B. Frangione. 1992. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135: 235-238.
16. 16. Strittmatter, W. J., A. M. Saunders, M. Goedert, K. H. Weisgraber, L-M. Dong, R. Jakes, D. Y. Huang, M. Pericak-Vance, D. Schmechel & A. D. Roses. 1994. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91: 11183-11186.
17. 17. Poirier, J., J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand & S. Gauthier. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
18. 18. Travis, J. 1993. New piece in Alzheimer's puzzle. Science 261: 828-829.
19. 19. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines & M. A. Pericak-Vance. 1993. Gene dose of Apolipoprotein type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:(13), 921-923.
20. 20. Doty, R. L., P. F. Reyes & T. P. Gregor. 1987. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res. Bull. 18(5): 597-600.
21. 21. Knupfer, L. & R. Spiegel. 1986. Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. Int. J. Geriatr. Psychiatry 1: 3-14.
22. 22. Koss, E., J. M. Weiffenbach, J. V. Haxby & R. P. Friedland. 1988. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 38: 1228-1232.
23. 23. Murphy, C., B. R. Lasker & D. P. Salmon. 1987. Olfactory dysfunction and odor memory in Alzheimer's disease, Huntington's disease and normal aging. Neurosci. Abstr. 13: 192.
24. 24. Schiffman, S. S., C. M. Clark & Z. S. Warwick. 1990. Gustatory and olfactory dysfunction in dementia: Not specific to Alzheimer's disease. Neurobiol. Aging 11(6): 597-600.
25. 25. Serby, M. 1986. Olfaction and Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 10: 579-586.
26. 26. Murphy, C., M. M. Gilmore, C. S. Seery, D. P. Salmon & B. R. Lasker. 1990. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol. Aging 11: 465-469.
27. 27. Nordin, S. & C. Murphy. 1996. Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. Neuropsychology 10(1): 112-119.
28. 28. Kesslack, J. P., C. W. Cotman, H. C. Chui, S. Van Den Noort, H. Fang, R. Pfeffer & G. Lynch. 1988. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease. Neurobiol. Aging 9: 399-403.
29. 29. Serby, M., P. Larson & D. Kalkstein. 1991. The nature and course of olfactory deficits in Alzheimer's disease. Am. J. Psychiatry 148: 357-360.
30. 30. Warner, M. D., C. A. Peabody, J. J. Flattery & J. R. Tinklenberg. 1986. Olfactory deficits and Alzheimer's disease. Biol. Psychiatry 21: 116-118.
31. 31. Morgan, C. D., S. Nordin & C. Murphy. 1995. Odor identification as an early marker for Alzheimer's disease: Impact of lexical functioning and detection sensitivity. J. Clin. Exp. Psychol. 17(5): 793-803.
32. 32. Koss, E. 1986. Olfactory dysfunction in Alzheimer's disease. Dev. Neuropsychol. 2: 89-99.
33. 33. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders. 3rd edit., revised. : 205-224. American Psychiatric Association. Washington, DC.
34. 34. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price & E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
35. 35. Wenham, P. R., W. H. Price & G. Blundell. 1991. Apolipoprotein E typing by one-stage PCR. Lancet 337: 1158-1159.
36. 36. Hixson, J. & D. Vernier. 1991. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhA1. J. Lipid Res. 31: 545-548.
37. 37. Folstein, M. F., S. E. Folstein & P. R. McHugh. 1975. Mini-Mental State. J. Psychiatr. Res. 12: 189-198.
38. 38. Mattis, S. 1988. Dementia Rating Scale (DRS). Psychological Assessment Resources. Odessa, FL.
39. 39. Bondi, M. W., A. U. Monsch, D. Galasko, N. Butters, D. P. Salmon & D. C. Delis. 1994. Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology 8: 374-384.
40. 40. LaRue, A., R. O'Hara, S. S. Matsuyama & L. F. Jarvick. 1995. Cognitive changes in young-old adults: Effect of family history of dementia. J. Clin. Exp. Neuropsychol. 17: 65-70.
41. 41. Jacobs, D. M., M. Sano, G. Dooneief, K. Marder, K. L. Bell & Y. Stern. 1995. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 45: 957-962.
42. 42. Peterson, R. C., G. Smith, R. J. Ivnik, E. G. Tangalos, D. J. Schaid, S. N. Thibodeau, E. Kokmen, S. C. Waring & L. T. Kurland. 1995. Apoplipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. J. Am. Med. Assoc. 273: 1274-1278.
43. 43. Reed, T., D. Carmelli, G. E. Swan et al. 1994. Lower cognitive performance in normal older adult male twins carrying the apoplipoprotein E e4 allele. Arch. Neurol. 51: 1189-1192.
44. 44. Bondi, M. W., D. P. Salmon, A. U. Monsch, D. Galasko, N. Butters, M. R. Klauber, L. J. Thal & T. Saitoh. 1995. Episodic memory changes are associated with the Apo-E ε4 allele in nondemented older adults. Neurology 45: 2203-2206.
45. 45. Linn, R. T., P. A. Wolf, D. L. Bachman, J. E. Knoefel, J. L. Cobb, A. J. Berlanger, E. F. Kaplan & R. B. D'Agostino. 1995. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch. Neurol. 52(5), 485-490.
46. 46. Masur, D. M., M. Sliwinski, R. B. Lipton et al. 1994. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44: 1427-1432.
47. 47. Sliwinski, M., R. B. Lipton, H. Buschke & W. Stewart. 1996. The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J. Gerontol. Psychol. Sci. 518: 217-225.